Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

60%

3 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 4

2(40.0%)

N/A

2(40.0%)

Phase 3

1(20.0%)

5Total

Phase 4(2)

N/A(2)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT01969786Not ApplicableActive Not Recruiting

Village Integrated Eye Workers Trial

Role: collaborator

NCT04837534Not ApplicableCompleted

Improving the Follow up Rate for Pediatric Patients

Role: collaborator

NCT05046041Phase 4Completed

Assessing Outpatient 'Day Procedure' for Second-trimester Medical Abortion at Two Public Sector Hospitals in Nepal

Role: collaborator

NCT03723525Phase 4Completed

Package of Care to Improve Retention in ART and Mortality Among Treatment Naive HIV Infected Individuals

Role: collaborator

NCT00997035Phase 3Completed

The Mycotic Ulcer Treatment Trial II: A Randomized Trial Comparing Oral Voriconazole vs Placebo

Role: collaborator

All 5 trials loaded